Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
01/2005
01/19/2005CN1565489A Wound repairing and burns treating cream
01/19/2005CN1565488A Kidney tonifying
01/19/2005CN1565487A Gynecopathy treating pills and its preparation method
01/19/2005CN1565486A Leucocyte increasing pills and its preparation method
01/19/2005CN1565485A Brain tonifying and kidney invigorating medicinal capsule
01/19/2005CN1565479A Musk liposome injection and its preparation method
01/19/2005CN1565477A Iodine microsphere clathrate compound and its preparation method and uses
01/19/2005CN1565476A Iodine ion injection liquid
01/19/2005CN1565475A Pertinent cure, immunity and prevention for atypical pneumonia, all kinds of virus infection of respiratory tract
01/19/2005CN1565472A Breviscapine slow release microsphere medicine formulation
01/19/2005CN1565471A Breviscapine drop pill
01/19/2005CN1565470A Antiparasitic medicine long-acting injection containing
01/19/2005CN1565469A Cornel extract oral medicine compositions low irritative to gastrointestinal tract and its preparation
01/19/2005CN1565468A S.japonica (Sw.) Ohwi flavone glucoside capsule and its production method
01/19/2005CN1565466A S.japonica (Sw.) Ohwi flavone glucoside injection and its preparing process
01/19/2005CN1565465A Injection preparation containing breviscapine active component and its preparation method
01/19/2005CN1565464A Haw effective part and its extracting method and uses
01/19/2005CN1565459A Dermatopathy therapeutic medicine compositions and its preparation method
01/19/2005CN1565454A Solid preparation for refreshment and its preparation method
01/19/2005CN1565451A Naloxone Hydrochloride nose powder preparation
01/19/2005CN1565450A Naloxone Hydrochloride Injection and its preparation method
01/19/2005CN1565449A Pyrroloquinoline containing composition for enriching zinc and reducing plumbum
01/19/2005CN1565446A Freeze-drying fluconazole injection and its preparation method
01/19/2005CN1565445A N-phenylpyrazoles drug containing long-acting injection for animals
01/19/2005CN1565444A Ramatroban glue pill and its preparation method
01/19/2005CN1565443A Daphnetin cyclodextrin clathrate compound, formulation and its preparation method
01/19/2005CN1565440A Silymarin Methylglucamine clathrate compound and its preparation method
01/19/2005CN1565437A Verapamil hydrochloric acid drop pill and its preparation method
01/19/2005CN1565436A Retinoic acid release control nanomicrosphere and its preparation method
01/19/2005CN1565434A Orally administered Modafinil medicine compostion
01/19/2005CN1565433A Hypocrellin water-soluble nanogranule and its uses
01/19/2005CN1565430A Allicin cyclodextrin clathrate compound, formulation and its preparation method
01/19/2005CN1565429A Instant oral film preparation and its preparation method
01/19/2005CN1565428A Chitosan microcapsule and its preparation method and uses
01/19/2005CN1565427A Gastric 5-fluorouracil double slow release tablet of float and stay type for curing gastric cancer
01/19/2005CN1565426A Formula containing water-soluble medicine slow release tablet and its preparation method
01/19/2005CN1565425A Rapid oral cavity disintegration tablet and its preparation method
01/19/2005CN1565424A Recombinant huaman alpha-interferon antiviral toothpaste
01/19/2005CN1565423A Ultra fine egg shell powder preparation method
01/19/2005CN1565422A AIDS drug didanosine granula composition and its preparation method
01/19/2005CN1565421A A set of externally used products capable of killing multiple pathogenic microorganism
01/19/2005CN1565420A Oral nano nourishing emulsion and its preparation method
01/19/2005CN1565419A Resin type matrix and its preparation method
01/19/2005CN1565418A Medicine plaster production process utilizing hot melted glue
01/19/2005CN1565410A Traditional Chinese medicine bag (lump) production and using method
01/19/2005CN1185013C 赋形剂 Excipient
01/19/2005CN1185009C Eye preparation
01/19/2005CN1185008C Therapeutic compositions containing glutathione analogs
01/19/2005CN1185007C Fat reducing and thrombosis dissolving medicine
01/19/2005CN1185006C Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof
01/19/2005CN1185004C Blood sugar and fat reducing medicinal capsule
01/19/2005CN1184999C Chinese medicinal herbs ointment and preparing method thereof
01/19/2005CN1184995C Kidney-strengthening and pregnancy assisting granule
01/19/2005CN1184990C Medicine bag for treating asthma
01/19/2005CN1184989C Weight-reducing Chinese medicine acted on acupoint
01/19/2005CN1184984C Chinese-medicinal ointment for treating burn and scald and its preparing process
01/19/2005CN1184975C Medicine for treating obsessional neurosis via head acupoint osmosis
01/19/2005CN1184971C Pharmaceutical combination preparations
01/19/2005CN1184970C Oral tablet containing 2-[(4-methoxy-3-methyl)-2-pyridyl]ethylsulfonyl-5-(1-H-pyrrole-1-yl)-1H-benzimidazole
01/19/2005CN1184962C Sertraline oral condensate
01/19/2005CN1184961C Use of EGF-R antagonists in preparing drug
01/19/2005CN1184960C Multiparticulate pharmaceutical formulation, particles constituting it, method and device for making same
01/19/2005CN1184959C Compositions containing ascorbic acid and pectin
01/19/2005CN1184958C Erythropoietin Liposomal dispersion
01/19/2005CN1184957C Intravaginal drug delivery devices for adminsitration of testosterone and testosterone precursors
01/19/2005CN1184903C Method for stabilizing liquid nutritional products and products so stabilized
01/19/2005CN1184897C Fluidizable and methionine containing shaped body and method for preparing same
01/18/2005US6844459 Pharmaceutical Composition
01/18/2005US6844364 Stabilization of retinoid compounds
01/18/2005US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation
01/18/2005US6844319 Targeting Hepatic Stellate Cells (HSC) involved in sclerotic and/or fibrotic diseases with carrier linked to amino acid sequence SRNLIDC
01/18/2005US6844306 Water-soluble, chlorhexidine-containing compositions and use thereof
01/18/2005US6844172 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems
01/18/2005US6844048 Substrates for powder deposition containing conductive domains
01/18/2005US6844010 Forming burst free, sustained, programmable release micro-capsules; dissolving active material and blend of glycolide-lactide polymers in methylene chloride; converting to water-oil-water emulsion; removing solvent and lyophilizing
01/18/2005US6844009 Media in the form of complex dispersions, method for preparing same and uses
01/18/2005US6844008 Tablet composition
01/18/2005US6844007 Uniform dispersion of solubilized and microcrystalline active material without use of solubilizier; antiinflammatory, analgesic agent contained in at least isoprene-styrene block copolymer, rosin-based resin, plasticizer and menthol
01/18/2005US6844005 Electrostatically charged nasal application product with increased strength
01/18/2005US6844004 Topical formulations of natamycin/pimaricin
01/18/2005US6843942 Method and device for producing lipid vesicles
01/18/2005US6843392 Valve with a valve stem wiper
01/18/2005CA2372194C Spray drying apparatus and methods of use
01/18/2005CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus
01/18/2005CA2064993C Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it
01/16/2005CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold
01/15/2005CA2464831A1 Stable non-dihydrate azithromycin oral suspensions
01/13/2005WO2005003722A2 Nanotube structures having a surfactant bilayer inner wall coating
01/13/2005WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles
01/13/2005WO2005003180A2 A method for the production of emulsion-based micro particles
01/13/2005WO2005003172A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
01/13/2005WO2005003168A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies
01/13/2005WO2005002643A2 Method and products for delivering biological molecules to cells using multicomponent nanostructures
01/13/2005WO2005002642A2 Medication infusion device using negatively biased ambient pressure medication chamber
01/13/2005WO2005002625A2 In-situ gelling drug delivery system
01/13/2005WO2005002595A1 Ophthalmic composition
01/13/2005WO2005002592A2 Stable oral compositions of azithromycin monohydrate
01/13/2005WO2005002588A1 Enteric coated composition comprising prostaglandin analogs as chloride channel opener
01/13/2005WO2005002581A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis
01/13/2005WO2005002569A1 Pellet preparation of ranitidine